[Inhibitive mechanisms of Pim-3 affecting fulminant hepatic apoptosis]

Liang-ming Liu1, Shui-lin Sun, Chang-gen Ye

  • 1Department of Liver Diseases, Songjiang Hospital Affiliated to the First People's Hospital, Shanghai Jiaotong University, China. liuliangming@hotmail.com

Insights

Serine/threonine kinase Pim-3 inhibits fulminant hepatic apoptosis by modulating apoptosis-related genes. Pim-3 gene injection suppressed liver injury and apoptosis markers, offering a potential therapeutic strategy.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Biochemistry

Background:

  • Fulminant hepatic apoptosis is a severe liver condition.
  • Serine/threonine kinase Pim-3's role in apoptosis is not fully understood.
  • Investigating Pim-3's mechanism in liver injury is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the protective mechanisms of serine/threonine kinase Pim-3 against fulminant hepatic apoptosis.
  • To determine the effect of Pim-3 gene on apoptosis-related gene expression in a rat model of liver injury.

Main Methods:

  • Rats were divided into four groups: control, Ringer's solution, vector plasmid, and Pim-3 recombinant plasmid.
  • Fulminant hepatic apoptosis was induced using lipopolysaccharide (LPS) and D-galactosamine (D-GalN).
  • Caspase-3 activity, gene expression (RT-PCR), and protein levels (Western blotting) were analyzed.

Main Results:

  • Pim-3 pretreatment significantly reduced caspase-3 activity compared to control groups.
  • Exogenous Pim-3 gene suppressed the expression of liver injury marker iNOS and apoptosis-related genes p53 and Bax.
  • Pim-3 gene upregulated the anti-apoptosis protein Bcl-2 without affecting Bax protein levels.

Conclusions:

  • The serine/threonine kinase Pim-3 gene can effectively block fulminant hepatic apoptosis.
  • Pim-3 exerts its protective effects by modulating the expression of iNOS, p53, Bax, and Bcl-2.
  • Pim-3 shows potential as a therapeutic agent for preventing severe liver apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...